Skip Navigation
Grant Details

Grant Number: 5R01CA081188-03 Interpret this number
Primary Investigator: Kaaks, Rudolf
Organization: International Agency For Res On Cancer
Project Title: Insulin, Igf-1 & Cancers of Breast, Endometrium & Ovary
Fiscal Year: 2001
Back to top


Abstract

A Western lifestyle, including type of diet, lack of physical activity, and certain childbearing patterns, is associated with high risks of cancers of the breast, endometrium, and ovary. A widely held view is that effects of lifestyle factors on cancer risk are mediated through alterations in hormone metabolism. One feature potentially shared by all three forms of cancer is ovarian overproduction of androgens. A second common feature may be elevated plasma and tissue levels of insulin or insulin-like growth factor-I (IGF-I), or decreased IGF-binding proteins. Insulin is a key hormone in the regulation of energy metabolism and, together with insulin-like growth factor-I, is also central in the regulation of anabolic (growth) processes as function of available energy and elementary substrates (e.g., amino acids). Increased levels of IGF-I, or decreased levels of IGF-binding proteins (IGFBPs), have been shown to promote tumor development by inhibiting apoptosis, and by stimulating cell proliferatton. In addition, insulin and IGF-I enhance ovarian androgen production and down regulate hepatic production and plasma levels of SHBG. The specific aim of the present proposal is to address the hypothesis that increased (prediagnostic) plasma levels of insulin; and/or increased plasma IGF-I for given concentrations of major IGFBPs (IGFBP-1, -2, -3) are associated with increased risk of ovarian and endometrial cancers and of breast cancer in young women. Through insulin and IGF-I, the study seeks to establish a linkage between exposure to Western lifestyle and over nutrition and imbalances in steroid hormones that are thought to be associated with the three cancers most frequently affecting women. This study is a component (Component 3) of a group of three concurrent studies which address complementary aspects of the role of endogenous hormones in the etiology of ovarian and endometrial cancers, and of breast cancer in young women. All studies are based on the same underlying population, obtained by combining three prospective cohort studies that are currently ongoing in New York, Umea (Sweden) and Milan (Italy).

Back to top


Publications

IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies.
Authors: Rinaldi S, Toniolo P, Muti P, Lundin E, Zeleniuch-Jacquotte A, Arslan A, Micheli A, Lenner P, Dossus L, Krogh V, Shore RE, Koenig KL, Riboli E, Stattin P, Berrino F, Hallmans G, Lukanova A, Kaaks R
Source: Eur J Cancer Prev, 2005 Dec;14(6), p. 493-6.
PMID: 16284492
Related Citations

Back to top


Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.
Authors: Lukanova A, Kaaks R
Source: Cancer Epidemiol Biomarkers Prev, 2005 Jan;14(1), p. 98-107.
PMID: 15668482
Related Citations

Back to top


Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Authors: Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, Dossus L, Riboli E, Stattin P, Lukanova A, Toniolo P
Source: Cancer Epidemiol Biomarkers Prev, 2005 Jan;14(1), p. 48-52.
PMID: 15668475
Related Citations

Back to top


Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women.
Authors: Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R
Source: Eur J Endocrinol, 2004 Feb;150(2), p. 161-71.
PMID: 14763914
Related Citations

Back to top


Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
Authors: Arslan AA, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Lukanova A, Afanasyeva Y, Lenner P, Krogh V, Muti P, Rinaldi S, Kaaks R, Berrino F, Hallmans G, Toniolo P
Source: Cancer Epidemiol Biomarkers Prev, 2003 Dec;12(12), p. 1531-5.
PMID: 14693749
Related Citations

Back to top


Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Authors: Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R
Source: Int J Cancer, 2004 Jan 10;108(2), p. 262-8.
PMID: 14639613
Related Citations

Back to top


Reliability of follicle-stimulating hormone measurements in serum.
Authors: Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, Rinaldi S, Kaaks R, Toniolo P
Source: Reprod Biol Endocrinol, 2003 Jun 18;1, p. 49.
EPub date: 2003 Jun 18.
PMID: 12844363
Related Citations

Back to top


Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
Authors: Lukanova A, Lundin E, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Riboli E, Hallmans G, Berrino F, Zeleniuch-Jacquotte A, Toniolo P, Kaaks R
Source: Cancer Causes Control, 2003 Apr;14(3), p. 285-92.
PMID: 12814208
Related Citations

Back to top


Circulating levels of sex steroid hormones and risk of ovarian cancer.
Authors: Lukanova A, Lundin E, Akhmedkhanov A, Micheli A, Rinaldi S, Zeleniuch-Jacquotte A, Lenner P, Muti P, Biessy C, Krogh V, Berrino F, Hallmans G, Riboli E, Kaaks R, Toniolo P
Source: Int J Cancer, 2003 May 1;104(5), p. 636-42.
PMID: 12594820
Related Citations

Back to top


Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Authors: Kaaks R, Lukanova A, Kurzer MS
Source: Cancer Epidemiol Biomarkers Prev, 2002 Dec;11(12), p. 1531-43.
PMID: 12496040
Related Citations

Back to top


Circulating levels of insulin-like growth factor-I and risk of ovarian cancer.
Authors: Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R
Source: Int J Cancer, 2002 Oct 20;101(6), p. 549-54.
PMID: 12237896
Related Citations

Back to top